Literature DB >> 1729607

Two conserved essential motifs of the murine immunoglobulin lambda enhancers bind B-cell-specific factors.

C M Rudin1, U Storb.   

Abstract

Two highly homologous enhancers associated with the two murine immunoglobulin lambda constant-region clusters were recently identified. In order to better understand the molecular basis for the developmental stage- and cell-type-restricted expression of lambda genes, we have undertaken an analysis of the putative regulatory domains of these enhancers. By using a combination of DNase I footprinting, electrophoretic mobility shift assay, and site-specific mutations, four candidate protein binding sites have been identified at analogous positions in both enhancers. A mutation of any of these sites decreases enhancer activity. Two of the sites, lambda A and lambda B, are essential for enhancer function, and both of these sites appear to bind both B-cell-specific and general factors. Nevertheless, isolated lambda A and lambda B sites show no evidence of inherent transactivating potential, alone or together, even when present in up to three copies. We suggest that the generation of transactivating signals from these enhancers may require the complex interaction of multiple B-cell-specific and nonspecific DNA-binding factors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1729607      PMCID: PMC364111          DOI: 10.1128/mcb.12.1.309-320.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  70 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Aberrant rearrangements contribute significantly to the allelic exclusion of immunoglobulin gene expression.

Authors:  C Coleclough; R P Perry; K Karjalainen; M Weigert
Journal:  Nature       Date:  1981-04-02       Impact factor: 49.962

3.  A method for the recovery of DNA from agarose gels.

Authors:  H F Tabak; R A Flavell
Journal:  Nucleic Acids Res       Date:  1978-07       Impact factor: 16.971

4.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

5.  Novel kappa light-chain gene rearrangements in mouse lambda light chain-producing B lymphocytes.

Authors:  J Durdik; M W Moore; E Selsing
Journal:  Nature       Date:  1984 Feb 23-29       Impact factor: 49.962

6.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

7.  Human immunoglobulin kappa light-chain genes are deleted or rearranged in lambda-producing B cells.

Authors:  P A Hieter; S J Korsmeyer; T A Waldmann; P Leder
Journal:  Nature       Date:  1981-04-02       Impact factor: 49.962

8.  Expression of a preproinsulin-beta-galactosidase gene fusion in mammalian cells.

Authors:  D A Nielsen; J Chou; A J MacKrell; M J Casadaban; D F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

9.  Cellular localization of immunoglobulins with different allotypic specificities in rabbit lymphoid tissues.

Authors:  B Pernis; G Chiappino; A S Kelus; P G Gell
Journal:  J Exp Med       Date:  1965-11-01       Impact factor: 14.307

10.  Rabbit lymphoid cells differentiated with respect to alpha-, gamma-, and mu- heavy polypeptide chains and to allotypic markers Aa1 and Aa2.

Authors:  J J Cebra; J E Colberg; S Dray
Journal:  J Exp Med       Date:  1966-03-01       Impact factor: 14.307

View more
  9 in total

1.  Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimers.

Authors:  A L Brass; A Q Zhu; H Singh
Journal:  EMBO J       Date:  1999-02-15       Impact factor: 11.598

2.  Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE).

Authors:  T Matsuyama; A Grossman; H W Mittrücker; D P Siderovski; F Kiefer; T Kawakami; C D Richardson; T Taniguchi; S K Yoshinaga; T W Mak
Journal:  Nucleic Acids Res       Date:  1995-06-25       Impact factor: 16.971

3.  The chicken immunoglobulin lambda light chain gene is transcriptionally controlled by a modularly organized enhancer and an octamer-dependent silencer.

Authors:  S Bulfone-Paus; L Reiners-Schramm; R Lauster
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

4.  PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.

Authors:  C F Eisenbeis; H Singh; U Storb
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

5.  E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development.

Authors:  Y Jacobs; C Vierra; C Nelson
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

6.  Distinct roles for E12 and E47 in B cell specification and the sequential rearrangement of immunoglobulin light chain loci.

Authors:  Kristina Beck; Mandy M Peak; Takayuki Ota; David Nemazee; Cornelis Murre
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

7.  Transcription-coupled eviction of histones H2A/H2B governs V(D)J recombination.

Authors:  Sarah Bevington; Joan Boyes
Journal:  EMBO J       Date:  2013-03-05       Impact factor: 11.598

8.  Crossing the SJL lambda locus into kappa-knockout mice reveals a dysfunction of the lambda 1-containing immunoglobulin receptor in B cell differentiation.

Authors:  J Y Kim; B Kurtz; D Huszar; U Storb
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

9.  Targeting of somatic hypermutation by immunoglobulin enhancer and enhancer-like sequences.

Authors:  Jean-Marie Buerstedde; Jukka Alinikula; Hiroshi Arakawa; Jessica J McDonald; David G Schatz
Journal:  PLoS Biol       Date:  2014-04-01       Impact factor: 8.029

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.